{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T12:48:19Z","timestamp":1772801299121,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.jneuroim.2010.08.022","type":"journal-article","created":{"date-parts":[[2010,9,25]],"date-time":"2010-09-25T04:40:11Z","timestamp":1285389611000},"page":"192-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice"],"prefix":"10.1016","volume":"229","author":[{"given":"Elizabeta","family":"Aizman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Mor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaniv","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.08.022_bb0005","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1523\/JNEUROSCI.1859-05.2005","article-title":"Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis","volume":"25","author":"Aharoni","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0010","doi-asserted-by":"crossref","first-page":"11358","DOI":"10.1073\/pnas.0804632105","article-title":"Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis","volume":"105","author":"Aharoni","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0015","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00702-009-0272-3","article-title":"Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate","volume":"116","author":"Arnon","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.imbio.2005.10.010","article-title":"Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms","volume":"210","author":"Aronovich","year":"2005","journal-title":"Immunobiology"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0025","doi-asserted-by":"crossref","unstructured":"Auray, G., Facci, M.R., van Kessel, J., Buchanan, R., Babiuk, L.A., Gerdts, V., Differential activation and maturation of two porcine DC populations following TLR ligand stimulation. Molecular Immunology. 47, 2103\u20132111.","DOI":"10.1016\/j.molimm.2010.03.016"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2008.07.018","article-title":"Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis","volume":"204","author":"Begum-Haque","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0035","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1091\/mbc.e07-10-1053","article-title":"Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters","volume":"19","author":"Belanis","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0040","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/BF00873697","article-title":"The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease","volume":"243","author":"Ben-Nun","year":"1996","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0045","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/107999099313703","article-title":"Quantitative PCR reveals increased levels of tumor necrosis factor-alpha mRNA in peripheral blood mononuclear cells of multiple sclerosis patients during relapses","volume":"19","author":"Bertolotto","year":"1999","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0050","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1073\/pnas.0504484102","article-title":"Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders","volume":"102","author":"Chorny","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0055","first-page":"555","article-title":"The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid chemosensitizes human tumor cells without causing resistance","volume":"8","author":"Gana-Weisz","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jneuroim.2004.09.006","article-title":"Additive effect of the combination of glatiramer acetate and minocycline in a model of MS","volume":"158","author":"Giuliani","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0065","doi-asserted-by":"crossref","first-page":"11709","DOI":"10.1158\/0008-5472.CAN-06-1878","article-title":"A Ras inhibitor tilts the balance between Rac and Rho and blocks PI3-kinase-dependent glioblastoma cell migration","volume":"66","author":"Goldberg","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.58.2.169","article-title":"Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines","volume":"58","author":"Goodin","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0075","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/bi972032d","article-title":"Dislodgment and accelerated degradation of Ras","volume":"37","author":"Haklai","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0080","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1191\/135245800678827851","article-title":"Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate","volume":"6","author":"Hogh","year":"2000","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0085","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1073\/pnas.0502187102","article-title":"Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3","volume":"102","author":"Hong","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0090","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.1772","article-title":"Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10","volume":"10","author":"Ilarregui","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0095","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/eji.200839179","article-title":"Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE","volume":"39","author":"Isaksson","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2005.07.008","article-title":"Inhibition of Ras attenuates the course of experimental autoimmune neuritis","volume":"168","author":"Kafri","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0167-5699(99)01547-9","article-title":"T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal","volume":"20","author":"Kalinski","year":"1999","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00385-X","article-title":"The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis","volume":"120","author":"Karussis","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0115","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-2249.2001.01674.x","article-title":"Treatment of MRL\/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS)","volume":"126","author":"Katzav","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1078\/0171-2985-00208","article-title":"Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome","volume":"207","author":"Katzav","year":"2003","journal-title":"Immunobiology"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0125","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1212\/WNL.57.6.1129","article-title":"TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS","volume":"57","author":"Killestein","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004678.pub2","article-title":"Glatiramer acetate for multiple sclerosis","author":"La Mantia","year":"2010","journal-title":"Cochrane Database Syst Rev 5, CD004678"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0135","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1182\/blood-2005-04-1531","article-title":"CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy","volume":"106","author":"Li","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-510X(83)90205-8","article-title":"Effect of treatment with Copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE)","volume":"62","author":"Lisak","year":"1983","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0150","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.2165\/0003495-200868170-00004","article-title":"Disease-modifying agents for multiple sclerosis: recent advances and future prospects","volume":"68","author":"Menge","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1664","article-title":"LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis","volume":"13","author":"Mi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0160","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/eji.200838292","article-title":"N-Ras or K-Ras inhibition increases the number and enhances the function of Foxp3 regulatory T cells","volume":"38","author":"Mor","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejphar.2009.06.001","article-title":"Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice","volume":"616","author":"Mor","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0170","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbi.2010.01.014","article-title":"Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis","volume":"24","author":"Murphy","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0175","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0180","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nri1845","article-title":"Dendritic cells in a mature age","volume":"6","author":"Reis e Sousa","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0185","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0076-6879(07)00432-6","article-title":"The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer","volume":"439","author":"Rotblat","year":"2008","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0190","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jneuroim.2008.04.032","article-title":"Combination treatment of glatiramer acetate and minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients","volume":"197","author":"Ruggieri","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1073\/pnas.0910620107","article-title":"FoxP3+ regulatory T cells essentially contribute to peripheral CD8+ T-cell tolerance induced by steady-state dendritic cells","volume":"107","author":"Schildknecht","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0200","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1158\/0008-5472.CAN-08-1117","article-title":"K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3","volume":"68","author":"Shalom-Feuerstein","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0210","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.4049\/jimmunol.170.9.4483","article-title":"Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells","volume":"170","author":"Vieira","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0215","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1074-7613(03)00113-4","article-title":"Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo","volume":"18","author":"Wakkach","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0220","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0002-9440(10)63466-9","article-title":"Complement C5 in experimental autoimmune encephalomyelitis (EAE) facilitates remyelination and prevents gliosis","volume":"163","author":"Weerth","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2010.08.022_bb0225","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1038\/sj.onc.1202602","article-title":"A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice","volume":"18","author":"Weisz","year":"1999","journal-title":"Oncogene"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810004030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:18:33Z","timestamp":1759047513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810004030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0165572810004030"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.08.022","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}